SCHEMBL5098144

SCHEMBL5098144

Cc1occc1C(=O)NC1(C(=O)O)CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
MAPK1 P28482 2/20 0.52
GLA P06280 1/20 0.52
KMT2A Q03164 2/20 0.48
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
PKM P14618 3/20 0.47
HTT P42858 3/20 0.47
TP53 P04637 2/20 0.47
STAT1 P42224 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TSHR P16473 1/20 0.47
ESR2 Q92731 1/20 0.47
POLB P06746 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
PYGL P06737 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1837001 0.80 KDM4E (0.47) KMT2ANPC1RAB9ASMN1; SMN2PKM
SCHEMBL13164041 0.75 PYGL (0.54) POLBCYP2C9PYGLHPGD
SCHEMBL1843420 0.74 KDM4E (0.52) LMNANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL5105697 0.72 SMN1; SMN2 (0.51) LMNANPC1RAB9ASMN1; SMN2PKM
SCHEMBL5097601 0.71 NPC1 (0.48) KMT2ANPC1RAB9ASMN1; SMN2TP53
SCHEMBL26332927 0.71 MAPK1 (0.61) LMNAMAPK1GLAKMT2ANPC1
SCHEMBL1837046 0.71 KCNK3 (0.44) RAB9ATSHRALDH1A1
SCHEMBL1836676 0.70 CTSK (0.61) LMNAMAPK1HTTCYP2C9CYP2C19
SCHEMBL1839461 0.70 CTSL (0.48) KMT2ANPC1RAB9ASMN1; SMN2POLB
SCHEMBL8317330 0.69 MAPK1 (0.62) LMNAMAPK1GLAKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US disclosed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US disclosed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof CTRL, PRCP, CLPP LMNA 3621/4885MAPK1 684/4885GLA 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.